In the investors eyes the Amazon agreement isn't an entry to the US - are more so awaiting a major distribution agreement into the US, whether via retail (wholefoods etc) or wholesale (like our $3.5M PathWay agreement for Aus for raw Kava ingredients/b2b)
Keeping in mind that the US is Kavas biggest international market, and AUS being relatively small, that $3.5M Aus contract and the $8M chinese contract as reference points as to what these sizeable contracts look like in other markets, I'm expecting a $5-15M if it's an exclusive wholesale/pharmaceutical US contract, alongside distribution deals such as wholefoods.
That really is the big one, the US market. Or alternatively it's a many smaller contracts if not exclusive.
In the investors eyes the Amazon agreement isn't an entry...
-
- There are more pages in this discussion • 927 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CCO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.34M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.8¢ | $49.94K | 6.243M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 6645086 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 2629599 | 12 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CCO (ASX) Chart |